TAIZHOU, China--(BUSINESS WIRE)--Favipiravir is a broad-spectrum antiviral agent that inhibits the RNA-dependent RNA polymerase of RNA viruses. It has efficacy against a range of RNA viruses, ...
TAIZHOU, China--(BUSINESS WIRE)--According to news on June 29 from Middle East News Agency, Favipiravir, the popular drug used for treating COVID-19 has shown excellent results in clinical tests. AP, ...
BENGALURU (Reuters) - India's Glenmark Pharmaceuticals Ltd said on Wednesday its version of anti-flu drug favipiravir showed promise in a late-stage study of 150 patients with mild to moderate ...
Treatment options for mild-to-moderate COVID-19 are becoming increasingly well established. A systematic review and network meta-analysis published in The BMJ evaluated 40 treatments across 187 ...
BENGALURU (Reuters) - Glenmark Pharmaceuticals Ltd defended the pricing of its generic version of favipiravir, FabiFlu, on Tuesday, after India's drug regulator had reportedly sent the company a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results